| Literature DB >> 26694460 |
Dong-Hwa Lee1, Kyeong Seon Park2, Soyeon Ahn3, Eu Jeong Ku4, Kyong Yeun Jung5, Yoon Ji Kim6, Kyoung Min Kim7, Jae Hoon Moon8, Sung Hee Choi9, Kyong Soo Park10, Hak Chul Jang11, Soo Lim12.
Abstract
We evaluated the concordance between visceral fat area (VFA) estimated by bioelectrical impedance analysis (BIA) or computed tomography (CT) in Korean subjects with a wide range in age and body mass index (BMI). In 1006 individuals (mean age 55.2 ± 11.8 (19-87) years, mean BMI 26.0 ± 3.5 (17-46) kg/m², 48.9% men), VFA quantified by CT was compared with VFA using multifrequency BIA machines within 15 days. Concordance rates were compared by age or BMI using correlation analysis, Bland-Altman plots, and intraclass correlation coefficient (ICC). Using BIA data, we established a regression formula to reflect CT-VFA. The mean VFAs by CT and BIA were 131.9 ± 57.3 cm² and 110.5 ± 33.9 cm², respectively (r = 0.605, p < 0.001). The mean difference was 21.4 ± 45.6 cm², tending to increase with BMI. In women with BMI <25 kg/m² or age <50 years, the VFAs by BIA were similar to those by CT (ICC = 0.496 in BMI <25 kg/m² and ICC = 0.638 in age <50 years). However, the difference was greater in men with BMI ≥25 kg/m² or age ≥50 years. Applying our formula, the difference between estimations decreased to 0.2 ± 38.2cm². VFA estimated by BIA correlated well with that by CT, but a more accurate formula is needed to match CT data, particularly in older men or subjects with a high BMI.Entities:
Keywords: Korean; bioelectrical impedance; computed tomography; visceral fat area
Mesh:
Substances:
Year: 2015 PMID: 26694460 PMCID: PMC4690100 DOI: 10.3390/nu7125548
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Anthropometric and biochemical characteristics and comorbidity of the study populations.
| All | Men | Women | ||
|---|---|---|---|---|
| ( | ( | ( | ||
| Age (years) | 55.2 ± 11.8 | 53.7 ± 11.9 | 56.7 ± 11.5 | <0.001 |
| Height (cm) | 163.4 ± 8.7 | 169.6 ± 6.1 | 157.4 ± 6.2 | <0.001 |
| Weight (kg) | 69.0 ± 12.4 | 74.8 ± 11.9 | 63.5 ± 10.1 | <0.001 |
| BMI (kg/m2) | 26.0 ± 3.5 | 26.1 ± 3.4 | 25.8 ± 3.6 | 0.193 |
| WC (cm) | 89.2 ± 9.5 | 91.8 ± 8.7 | 86.7 ± 9.5 | <0.001 |
| SBP (mmHg) | 129.6 ± 15.2 | 130.5 ± 16.0 | 128.7 ± 14.4 | 0.059 |
| DBP (mmHg) | 78.1 ± 10.8 | 79.5 ± 10.9 | 76.7 ± 10.6 | <0.001 |
| FPG (mg/dL) | 138.1 ± 48.9 | 143.6 ± 49.4 | 132.2 ± 47.8 | 0.001 |
| A1c (%) | 7.1 ± 1.8 | 7.3 ± 1.8 | 7.0 ± 1.8 | 0.018 |
| WBC (103/μL) | 6.65 ± 2.13 | 7.02 ± 2.28 | 6.32 ± 1.93 | <0.001 |
| Hemoglobin (g/dL) | 14.2 ± 1.7 | 15.1 ± 1.5 | 13.4 ± 1.4 | <0.001 |
| Hematocrit (%) | 42.7 ± 4.5 | 45.1 ± 4.0 | 40.6 ± 3.7 | <0.001 |
| Platelet (103/μL) | 241.1 ± 58.2 | 227.6 ± 57.0 | 253.1 ± 56.7 | <0.001 |
| Total cholesterol (mg/dL) | 200.9 ± 41.6 | 197.5 ± 40.8 | 204.2 ± 42.0 | 0.011 |
| Triglycerides (mg/dL) | 156.2 ± 94.7 | 165.5 ± 97.3 | 147.7 ± 91.5 | 0.005 |
| HDL-cholesterol (mg/dL) | 52.5 ± 14.4 | 49.9 ± 15.5 | 55.0 ± 12.9 | <0.001 |
| LDL-cholesterol (mg/dL) | 109.2 ± 31.1 | 110.4 ± 31.0 | 108.2 ± 31.3 | 0.281 |
| BUN (mg/dL) | 14.7 ± 4.6 | 15.1 ± 4.4 | 14.3 ± 4.7 | 0.003 |
| Cr (mg/dL) | 0.97 ± 0.21 | 1.07 ± 0.19 | 0.88 ± 0.18 | <0.001 |
| eGFR (mL/min/1.73 m2) | 76.0 ± 16.0 | 78.9 ± 16.3 | 73.2 ± 15.2 | <0.001 |
| AST (IU/L) | 27.3 ± 17.3 | 29.7 ± 21.2 | 25.0 ± 12.0 | <0.001 |
| ALT (IU/L) | 32.8 ± 28.7 | 38.3 ± 35.2 | 27.4 ± 19.1 | <0.001 |
| VFA by CT (cm2) | 131.9 ± 57.3 | 145.1 ± 60.4 | 119.3 ± 51.1 | <0.001 |
| SFA by CT (cm2) | 182.2 ± 83.9 | 148.2 ± 73.4 | 214.7 ± 80.5 | <0.001 |
| Total body water (L) | 35.6 ± 7.1 | 41.0 ± 5.1 | 30.4 ± 4.3 | <0.001 |
| Lean body mass (kg) | 45.7 ± 9.2 | 52.7 ± 6.6 | 39.0 ± 5.8 | <0.001 |
| Whole body fat mass (kg) | 21.2 ± 7.5 | 19.8 ± 7.7 | 22.5 ± 7.0 | <0.001 |
| Whole body fat percent (%) | 30.3 ± 8.1 | 25.6 ± 6.4 | 34.8 ± 6.8 | <0.001 |
| VFA by BIA (cm2) | 110.5 ± 33.9 | 106.9 ± 34.9 | 113.9 ± 32.6 | 0.001 |
| Smoking | ||||
| non/ex-/current | 61.8/18.7/19.5 | 27.3/35.3/37.4 | 95.1/2.8/2.1 | <0.001 |
| Alcohol | ||||
| non/light to moderate/heavy | 60.3/31.2/8.5 | 35.8/49.9/14.3 | 84.3/12.9/2.8 | <0.001 |
| Exercise | ||||
| Regular/irregular or Non | 57.3/42.7 | 59.7/40.3 | 54.9/45.1 | 0.002 |
| Diabetes mellitus | 664 (66.0) | 358 (72.8) | 306 (59.5) | <0.001 |
| Hypertension | 408 (40.8) | 199 (40.7) | 209 (40.8) | 0.968 |
| Dyslipidemia | 441 (45.1) | 212 (44.4) | 229 (45.8) | 0.649 |
| Diuretics | 122 (12.1) | 59 (12.0) | 63 (12.3) | 0.898 |
| Thiazolidinedione | 47 (4.7) | 26 (5.3) | 21 (4.1) | 0.368 |
Data are expressed as the mean ± SD. BMI, body mass index; WC, waist circumference; SBP, systolic blood pressure; DBP, diastolic blood pressure; WBC, white blood cell; FPG, fasting plasma glucose; LDL, low-density lipoprotein; HDL, high-density lipoprotein; BUN, blood urea nitrogen; Cr, creatinine; VFA, visceral fat area; SFA, subcutaneous fat area. *p values by Student’s t test between men and women.
Figure 1Correlation between VFA measured by CT and VFA estimated by BIA (A) and Bland-Altman plot for comparing the two methods (B).
Mean differences of VFAs observed by CT and BIA according to the gender, body mass index, and age groups.
| N | CT-VFA (cm2) | BIA-VFA (cm2) | CT-VFA-BIA-VFA (cm2) | * | † | ICC | |
|---|---|---|---|---|---|---|---|
| Total | 1006 | 131.9 ± 57.3 | 110.5 ± 33.9 | 21.4 ± 45.6 | <0.001 | 0.481 | |
| Gender | <0.001 | ||||||
| Men | 492 | 145.1 ± 60.4 | 106.9 ± 34.9 | 38.2 ± 45.9 | <0.001 | 0.438 | |
| Women | 512 | 119.3 ± 51.1 | 113.9 ± 32.6 | 5.4 ± 39.2 | 0.002 | 0.577 | |
| BMI (kg/m2) | <0.001 | ||||||
| <20 | 23 | 53.5 ± 24.1 | 67.6 ± 16.4 | −14.1 ± 29.2 | 0.031 | −0.008 | |
| 20–22.9 | 161 | 81.1 ± 37.2 | 77.8 ± 22.9 | 3.2 ± 33.3 | 0.218 | 0.417 | |
| 23–24.9 | 232 | 113.3 ± 42.7 | 98.3 ± 23.5 | 15.0 ± 39.3 | <0.001 | 0.319 | |
| 25–26.9 | 248 | 138.6 ± 44.3 | 108.9 ± 19.4 | 29.7 ± 43.5 | <0.001 | 0.140 | |
| 27–29.9 | 223 | 158.0 ± 52.0 | 125.3 ± 22.8 | 32.8 ± 48.8 | <0.001 | 0.196 | |
| ≥30 | 119 | 189.3 ± 55.9 | 162.1 ± 31.4 | 27.2 ± 58.4 | <0.001 | 0.145 | |
| Age (years) | 0.050 | ||||||
| 19–39 | 95 | 107.8 ± 64.8 | 99.3 ± 42.8 | 8.5 ± 52.2 | 0.115 | 0.544 | |
| 40–49 | 205 | 123.5 ± 50.4 | 101.8 ± 33.8 | 21.7 ± 40.4 | <0.001 | 0.496 | |
| 50–59 | 314 | 131.3 ± 55.1 | 106.8 ± 30.3 | 24.4 ± 44.7 | <0.001 | 0.430 | |
| 60–69 | 291 | 138.1 ± 55.4 | 116.9 ± 30.5 | 21.2 ± 45.3 | <0.001 | 0.438 | |
| ≥70 | 101 | 155.8 ± 64.0 | 131.2 ± 32.9 | 24.6 ± 51.4 | <0.001 | 0.441 | |
Data are expressed as the mean ± SD. *p values by paired t test between CT-VFA and BIA-VFA. †p values by One-way ANOVA for changes across groups.
Pearson correlation between VFA measured by CT and VFA estimated by BIA in subgroups according to clinical features.
| * | † | ||||
|---|---|---|---|---|---|
| Hb ≥ 12 g/dL | 662 | 0.652 | <0.001 | 0.219 | |
| Hb < 12 g/dL | 37 | 0.510 | 0.001 | ||
| eGFR ≥ 60 mL/min/1.73 m2 | 740 | 0.630 | <0.001 | 0.327 | |
| eGFR < 60 mL/min/1.73 m2 | 103 | 0.563 | <0.001 | ||
| ALT ≥ 40 IU/L | 227 | 0.607 | <0.001 | 0.569 | |
| ALT < 40 IU/L | 771 | 0.579 | <0.001 | ||
| AST ≥ 40 IU/L | 111 | 0.503 | <0.001 | 0.144 | |
| AST < 40 IU/L | 887 | 0.606 | <0.001 | ||
| DM (−) | 342 | 0.625 | <0.001 | 0.516 | |
| DM (+) | 664 | 0.598 | <0.001 | ||
| HbA1c < 8% | 428 | 0.574 | <0.001 | 0.223 | |
| HbA1c ≥ 8% | 236 | 0.637 | <0.001 | ||
| Diuretics (−) and Thiazolidinedione (−) | 823 | 0.608 | <0.001 | ||
| Thiazolidinedione (+) | 47 | 0.659 | <0.001 | 0.484 | |
| Diuretics (+) | 122 | 0.564 | <0.001 | 0.430 |
*p values by persons correlation analysis between CT-VFA and BIA-VFA. values by Fisher z-test between correlation coefficients.
Figure 2Differences in VFA between CT and BIA methods according to BMI (A) and subjects age (B).
Subgroup analyses of mean differences between CT-VFA and BIA-VFA by gender.
| CT-VFA (cm2) | BIA-VFA (cm2) | CT-VFA–BIA-VFA (cm2) | ICC | |||
|---|---|---|---|---|---|---|
| BMI (kg/m2) | ||||||
| <25 | 188 | 105.4 ± 45.0 | 84.2 ± 28.0 | 21.2 ± 37.8 | <0.001 | 0.424 |
| ≥ 25 | 304 | 169.6 ± 55.6 | 120.9 ± 31.2 | 48.8 ± 47.3 | <0.001 | 0.285 |
| Age (years) | ||||||
| <50 | 175 | 132.4 ± 56.7 | 98.9 ± 36.9 | 33.5 ± 43.4 | <0.001 | 0.472 |
| ≥50 | 317 | 152.1 ± 61.4 | 111.3 ± 33.0 | 40.8 ± 47.0 | <0.001 | 0.407 |
| BMI (kg/m2) | ||||||
| <25 | 228 | 91.0 ± 42.0 | 92.4 ± 22.4 | −1.4 ± 33.8 | 0.539 | 0.496 |
| ≥25 | 286 | 141.8 ± 46.3 | 131.1 ± 29.1 | 10.7 ± 42.3 | <0.001 | 0.387 |
| Age (years) | ||||||
| <50 | 125 | 99.1 ± 48.3 | 104.0 ± 36.8 | −4.9 ± 36.4 | 0.135 | 0.638 |
| ≥50 | 389 | 125.8 ± 50.3 | 117.1 ± 30.5 | 8.7 ± 39.6 | <0.001 | 0.537 |
Data are expressed as the mean ± SD; p values by paired t test between CT-VFA and BIA-VFA.
Figure 3Calibration plots of prediction model in men (A) and women (B).
Multivariate regression models for prediction of VFA measured by CT according to gender.
| Men | Women | |||||
|---|---|---|---|---|---|---|
| Coefficient | 95% CI | Coefficient | 95% CI | |||
| Lower | Upper | Lower | Upper | |||
| Intercept | −184.51 | −323.06 | −45.95 | −142.77 | −277.24 | −8.30 |
| BIA-VFA | 1.11 | 0.46 | 1.76 | 1.40 | 0.72 | 2.08 |
| Age | −1.49 | −3.61 | 0.63 | −1.29 | −3.68 | 1.10 |
| BMI | 2.10 | −3.28 | 7.47 | −0.98 | −6.49 | 4.54 |
| WC | 2.03 | 1.33 | 2.72 | 2.14 | 1.55 | 2.73 |
| BIA-VFA*BMI | −0.02 | −0.04 | 0.01 | −0.03 | −0.05 | −0.01 |
| Age*BMI | 0.08 | −0.01 | 0.16 | 0.07 | −0.02 | 0.17 |
Figure 4Correlation between VFA measured by CT and VFA estimated by BIA (A) and Bland-Altman plot for comparison between two methods (B) in subjects who performed CT and BIA within seven days.